Evidence map›Paper›PMID 32335862›Full record

ArticleMonash bioethics review2020

Bioethical implications of end-of-life decision-making in patients with dementia: a tale of two societies.

Jaime D Mondragón, Latife Salame-Khouri, Arnoldo S Kraus-Weisman, Peter P De Deyn

Abstract read
In one paragraph

Article in Monash bioethics review, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jaime D MondragónDepartment of Neurology, University of Groningen, University Medical Center Groningen, PO Box 30001, 9700 RB, Groningen, The Netherlands. j.d.mondragon.uribe@umcg.nl.ORCID http://orcid.org/0000-0001-6416-4942
Latife Salame-KhouriFacultad de Medicina, Unidad de Posgrado, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Arnoldo S Kraus-WeismanFacultad de Medicina, Unidad de Posgrado, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Peter P De DeynDepartment of Neurology, University of Groningen, University Medical Center Groningen, PO Box 30001, 9700 RB, Groningen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

End-of-life decision-making in patients with dementia is a complex topic. Belgium and the Netherlands have been at the forefront of legislative advancement and progressive societal changes concerning the perspectives toward physician-assisted death (PAD). Careful consideration of clinical and social aspects is essential during the end-of-life decision-making process in patients with dementia. Geriatric assent provides the physician, the patient and his family the opportunity to end life with dignity. Unbearable suffering, decisional competence, and awareness of memory deficits are among the clinical considerations that physicians should incorporate during the end-of-life decision-making process. However, as other societies introduce legislature granting the right of PAD, new social determinants should be considered; Mexico City is an example. Current perspectives regarding advance euthanasia directives (AED) and PAD in patients with dementia are evolving. A new perspective that hinges on the role of the family and geriatric assent should help culturally heterogeneous societies in the transition of their public health care policies regarding end-of-life choices.

Indexed as

DementiaEthics, MedicalLegislation, MedicalAdvance DirectivesAgedBelgiumBioethicsCultureDecision MakingEuthanasiaFamilyHumansInformed ConsentMexicoNetherlandsPersonhoodAnosognosiaBioethicalDecision-makingDementiaEuthanasia

Identifiers

PMID32335862
PMCPMC7205770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.